During the past decade, Blood Transfusion Centre of Slovenia conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blood Transfusion Centre of Slovenia" #1 collaborator was "Blood Transfusion Centre of Slovenia" with 1 trials as a collaborator and "University Medical Centre Ljubljana" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Blood Transfusion Centre of Slovenia" are "Gene Expression" (1 trials), "Glioma" (1 trials), "Immunological Status" (1 trials) and "Metabolomics" (1 trials). Many other conditions were trialed in "Blood Transfusion Centre of Slovenia" in a lesser frequency.

Most popular intervention types in "Blood Transfusion Centre of Slovenia" are "Other" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Blood sampling" (2 trials) and "Glioma resection" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blood Transfusion Centre of Slovenia" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Blood Transfusion Centre of Slovenia". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Blood Transfusion Centre of Slovenia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Blood Transfusion Centre of Slovenia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".